We guide our patients to optimal sleep hygiene and habits to improve patient results.
Benefits of Myofunctional Therapy
Obstructive sleep apnea (OSA) is one of the most sleep breathing disorders. It is characterized by hypopnea or apnea airway obstruction, and manifests as snoring, choking, or gasping during sleep, daytime sleepiness, and startled awakening. It has been estimated that its prevalence in the general population varies from 6% to 38%, or to be as high as 49% among elderly population. OSA is a nighttime disorder characterized by repeated airway collapse that results in hypoxemia and frequent arousal from sleep. OSA coexists with hypertension in 50% of patients and with an increased risk for cardiovascular morbidity and mortality.
Orofacial Myofunctional Therapy (OMT) offers a low cost, nonpharmacologic means of improving sleep and blood pressure in patients who are intolerant of CPAP or as an adjunct treatment to patients who are on CPAP. OMT can significantly reduce obstructive sleep apnea severity and symptoms and represent a promising treatment for moderate obstructive sleep apnea.
The WASM World Congress on Sleep Medicine and the IPSA International Pediatric Sleep Congress have singled out myofunctional therapy for its efficacy and promise.
Outcomes of Myofunctional Therapy and Respiratory Training
Improved blood pressure (BP) and autonomic balance in hypertensive patients
Decreases apnea-hypopnea index by approximately 50% in adults
Decreased apnea-hypopnea index by approximately 62% in children.
Lowest oxygen saturation, snoring, and sleepiness outcomes improve in adults.
Improved respiratory muscle strength that improves swallowing
Restoration of Nasal Breathing